RUNX1 p.Pro384Ser
c.1150C>T · rs2056456531 · VCV1019366
ClinGen expert panel — Myeloid Malignancy VCEP
Uncertain Significance for hereditary thrombocytopenia and hematologic cancer predisposition syndrome. Applied ACMG criteria (verbatim):
PM2_Supporting
Curation rationale (ClinGen, verbatim)
NM_001754.5(RUNX1):c.1150C>T (p.Pro384Ser) is a missense variant which is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_Supporting). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_Supporting.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2552 | likely benign |
|---|---|---|
| REVEL | 0.8 | moderately pathogenic-leaning |
| SaProt | LLR -8.71 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.7, phastCons 1 |
| Regional constraint | o/e 0.87 | unconstrained · MANE · 42 kb · p 0.0085 · regional, not allelic |
| Overall | ||
| CADD | 25.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P357S vs ClinVar P384S) — verify the residue.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- RUNX1
- Protein
- p.Pro384Ser
- Coding
- c.1150C>T
- MANE Select
- NM_001754
- dbSNP
- rs2056456531
- Type
- single nucleotide variant
- Location
- chr21:34792428 (GRCh38)
- Gene constraint
- LOEUF 0.633 · pLI 0.29 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 61.76 · 5 PDB
- Residue 384
- the 'interaction with foxp3' region; the 'interaction with kat6b' region
Disease context
hereditary thrombocytopenia and hematologic cancer predisposition syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
For Familial platelet disorder with associated myeloid malignancy (Orphanet):
- Inheritance
- Autosomal dominant
Similar variants
- RUNX1 p.Pro384Leu Uncertain significance ★★★ ⚠ same residue
- RUNX1 p.Pro384Thr Uncertain significance ★★★ ⚠ same residue
- RUNX1 p.Pro384= Likely benign ★★★ same residue
- RUNX1 c.351+1G>A Pathogenic ★★★ same condition
- RUNX1 c.351+1G>C Likely pathogenic ★★★ same condition
- RUNX1 c.351+1G>T Pathogenic ★★★ same condition
- RUNX1 c.351+2T>A Likely pathogenic ★★★ same condition
- RUNX1 c.351+2T>C Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/runx1-p-pro384ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown